Cargando…
Meningococcal B vaccine and the vision of a meningitis free world
A century of traditional vaccinology lost the fight against meningococcus serogroup B (MenB). However, thanks to an innovative genome-based approach, the first broadly effective MenB vaccine, Bexsero(®) (GSK Vaccines), was developed and has been licensed for use in various age groups by the European...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Pacini Editore SPA
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755123/ https://www.ncbi.nlm.nih.gov/pubmed/26788735 |